VTESSE GROUP
The Vtesse network is one of the largest national networks in the UK, connecting 55 datacentres and 48 major towns and cities in England, Scotland and Wales. The company provides metropolitan and Wide Area Network solutions to some of the largest companies in the world both directly and via leading global system integrators, such as IBM, ARUP, Redstone and Logicalis. Its enterprise customers including Lloyds TSB, Poundland, Friends Provident, Invesco, DEFRA and the AA, will now have access to Interoute’s advanced Unified ICT portfolio of services.
VTESSE GROUP
Industry:
Information Technology Internet Professional Networking Software
Founded:
1999-01-01
Address:
Hertford, Hertford, United Kingdom
Country:
United Kingdom
Website Url:
http://www.vtesse.com
Total Employee:
1001+
Status:
Closed
Contact:
+4401992582100
Email Addresses:
[email protected]
Technology used in webpage:
GeoTrust SSL RapidSSL British Server Location
Similar Organizations
Apiant
APIANT offers Data Integration Software Solutions.
Central Data Systems
Systems Integration and Data Centre operations
Cygate Oy
Cygate Oy is a provider of secure network and data center solutions.
Diverse Networks
Diverse Networks is a provider of network management and data center services to companies.
Kruvi Solutions
Time Management and Workforce Management Solutions
OPEN KNOWLEDGE NETWORK
Learning Management System, Knowledge, Communication
PacketTrap Networks
PacketTrap Networks provides network and application management software solutions.
RapidStream
Networking services and solutions
Techamist
Developing software solutions
More informations about "Vtesse group"
Vtesse - Crunchbase Company Profile & Funding
Vtesse, Inc. is a rare disease company dedicated to developing drugs for patients suffering from diseases that are underserved. The first spin-out company from Cydan Development, Inc., an …See details»
Vtesse Company Profile 2024: Valuation, Investors, Acquisition
Developer of new drug treatments designed to treat severe and life-threatening diseases. The company's new drug treatments, includes treatment for rare disease Niemann-Pick Disease …See details»
Vtesse Company Profile - Office Locations, Competitors ... - Craft
Vtesse is based in Gaithersburg, Maryland. See insights on Vtesse including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Fledgling biotech Vtesse in $200M buyout from struggling Sucampo
Apr 3, 2017 · Despite only coming into life two years ago, Pfizer and NEA-backed upstart Vtesse has already seen its rare disease candidate VTS-270, for Niemann-Pick disease type C1, nab …See details»
Vtesse Pharma - The Lundbeck Foundation
Developed VTS-270 to treat patients with Niemann-Pick Disease Type C. The Lundbeck Foundation annually distributes more than DKK 500 mio. to Danish-based healthcare science …See details»
Vtesse - Products, Competitors, Financials, Employees, …
Vtesse is a rare disease company dedicated to developing drugs for patients suffering from underserved diseases. Vtesse closely collaborates with National Institutes of Health (NIH), …See details»
Vtesse - Funding, Financials, Valuation & Investors - Crunchbase
Vtesse is funded by 5 investors. Alexandria and Lundbeckfonden Ventures are the most recent investors. Which investors participated in the most funding rounds?See details»
Leading Life Science Syndicate Commits $25 Million to Series A …
Jan 7, 2015 · Vtesse is the first spin-off company for Cydan Development, Inc., an orphan-drug accelerator that shares with Vtesse the same syndicate of leading life sciences investors that …See details»
Vtesse Secures Additional $17 Million in Series A Extension to …
GAITHERSBURG, Md., July 25, 2016 /PRNewswire/ -- Vtesse, Inc., a company committed to developing drugs that will benefit patients with extremely rare, life-threatening diseases, …See details»
Sucampo buys start-up Vtesse | C&EN Global Enterprise - ACS …
Sucampo Pharmaceuticals will pay $200 million in stock and cash to acquire Vtesse, a privately held firm focused on rare diseases. Launched in January 2015, Vtesse was the first spin-off …See details»
Vtesse group - Crunchbase Company Profile & Funding
The Vtesse network is one of the largest national networks in the UK, connecting 55 datacentres and 48 major towns and cities in England, Scotland and Wales. The company provides …See details»
FOR IMMEDIATE RELEASE Medicines and Healthcare Products
Gaithersburg, MD, November 2, 2016 – Vtesse, Inc., a company committed to developing drugs that will benefit patients with extremely rare, life-threatening diseases, announced today that …See details»
Sucampo Acquires Vtesse for $200M to Acquire Pivotal-Stage …
Apr 3, 2017 · Sucampo Pharmaceuticals has purchased rare disease drugs firm, Vtesse, for $200 million in cash and shares, to bolster its pipeline with the latter’s late-stage drug candidate, …See details»
Sucampo Acquires Vtesse // Cooley // Global Law Firm
San Diego – April 12, 2017 – Cooley advised Sucampo Pharmaceuticals on its acquisition of rare disease biotech firm Vtesse for $200 million in cash and stock in upfront payments and …See details»
FOR IMMEDIATE RELEASE Vtesse, Inc. Announces FDA’s Granting …
Gaithersburg, MD, January 6, 2016 – Vtesse, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted its drug candidate, VTS-270 for treatment of Niemann-Pick …See details»
WilmerHale Reps Vtesse Inc. in Acquisition by Sucampo
Apr 3, 2017 · Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, and Vtesse Inc., a privately-held rare disease company, today announced that Sucampo has acquired …See details»
Vtesse, a rare disease company launches with $25M Series A
Jan 7, 2015 · Gaithersburg, MD, and Cambridge, MA, January 7, 2015 – Vtesse, Inc., a rare disease company focused on developing drugs for Niemann-Pick Disease Type C (NPC) and …See details»
Biotech startup Vtesse granted FDA breakthrough designation for …
Jan 6, 2016 · Biotech startup Vtesse on Wednesday announced the FDA has granted a breakthrough therapy designation to its lead drug candidate VTS-270 for treatment of …See details»
Vtesse - LinkedIn
Our advanced fibre optic network connects the business hubs of Europe, nearly 200 data centres and colocation facilities to America, Africa, Asia and network partners across the globe....See details»
Vitesse Energy, Inc. (VTS) Stock Price, News, Quote & History
Vitesse Energy, Inc., together with its subsidiaries, engages in the acquisition, development, and production of non-operated oil and natural gas properties in the United States. It owns and...See details»